Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
A Study to Assess the Effect of Povorcitinib on Digoxin, Rosuvastatin, and Metformin Pharmacokinetics and the Effect of Probenecid on Povorcitinib Pharmacokinetics When Administered Orally to Healthy Adult Participants
- Status
- COMPLETED
- Phase
- PHASE1
Topical Ruxolitinib Evaluation in Immune-related Lichenoid Skin-Toxicities
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Drug Interaction Between Povorcitinib and the Oral Contraceptive Levonorgestrel/Ethinyl Estradiol in Healthy Adult Females
- Status
- COMPLETED
- Phase
- PHASE1
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
- Status
- RECRUITING
- Phase
- PHASE2
Pre-Transplant INCBB099280 for Hepatocellular Carcinoma (HCC)
- Status
- WITHDRAWN
- Phase
- PHASE1
Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants.
- Status
- COMPLETED
- Phase
- PHASE1
A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Pemigatinib + Afatinib in Advanced Refractory Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma
- Status
- RECRUITING
- Phase
- EARLY_PHASE1